In vitro activity of A-86719.1, a novel 2-pyridone antimicrobial agent.
AUTOR(ES)
Eliopoulos, G M
RESUMO
This study evaluated the in vitro activity of A-86719.1, a novel 2-pyridone antimicrobial agent. The drug inhibited all tested members of the family Enterobacteriaceae at < or = 0.5 microgram/ml and all tested Pseudomonas aeruginosa, Burkholderia (Pseudomonas) cepacia, and Xanthomonas maltophilia strains at < or = 2 micrograms/ml. All but two strains of gram-positive bacteria were inhibited by < or = 1 microgram of the new drug per ml, including isolates highly resistant to ciprofloxacin.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=162641Documentos Relacionados
- In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent.
- Synthesis and antimicrobial activity of chromone-linked 2-pyridone fused with 1,2,4-triazoles, 1,2,4-triazines and 1,2,4-triazepines ring systems
- Comparative in vitro activity of SM7338, a new carbapenem antimicrobial agent.
- Comparative in vitro activity of WIN 57273, a new fluoroquinolone antimicrobial agent.
- In vitro and in vivo antibacterial activity of FR-31564, a phosphonic acid antimicrobial agent.
